A systematic review of the efficacy of prophylactic control measures for naturally-occurring canine leishmaniosis, part I: Vaccinations

Preventive Veterinary Medicine

Volumn 117, Issue 1, 2014, Pages 7-18

  Wylie, C E ^a   Carbonell Antonanzas M ^a   Aiassa, E ^b   Dhollander, S ^b   Zagmutt, F J ^c   Brodbelt, D C ^d   Solano Gallego, L ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b EUROPEAN FOOD SAFETY AUTHORITY   (Italy)

^c EpiX Analytics   (United States)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Canine; Leishmania infantum; Leishmaniosis; Systematic review; Vaccination

Indexed keywords

LEISHMANIA VACCINE;

ANIMAL; DOG; DOG DISEASES; IMMUNOLOGY; LEISHMANIASIS; PARASITOLOGY; VETERINARY;

ANIMALS; DOG DISEASES; DOGS; LEISHMANIASIS; LEISHMANIASIS VACCINES;

EID: 84910124704     PISSN: 01675877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prevetmed.2014.06.015     Document Type: Review

References (43)

1. An Introduction to Categorical Data Analysis 2007, John Wiley & Sons Inc., United States of America. A. Agresti (Ed.).
2. Baneth G., Koutinas A.F., Solano-Gallego L., Bourdeau P., Ferrer L. Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. 2008, 24:324-330.
3. Berrahal F., Mary C., Roze M., Berenger A., Escoffier K., Lamouroux D., Dunan S. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am. J. Trop. Med. Hyg. 1996, 55:273-277.
4. Borja-Cabrera G.P., Pontes N.N.C., Silva V.O.d., Souza E.P.d., Santos W.R., Gomes E.M., Luz K.G., Palatnik M., Sousa C.B.P.d. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN). Vaccine 2002, 20:3277-3284.
5. ® vaccine against canine visceral leishmaniasis in Brazil. Vaccine 2008, 26:4991-4997.
6. Cabral M., O'Grady J.E., Gomes S., Sousa J.C., Thompson H., Alexander J. The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs. Vet. Parasitol. 1998, 76:173-180.
7. Cardoso L., Neto F., Sousa J.C., Rodrigues M., Cabral M. Use of a leishmanin skin test in the detection of canine Leishmania-specific cellular immunity. Vet. Parasitol. 1998, 79:213-220.
8. da Silva V.O., Borja-Cabrera G.P., Correia Pontes N.N., de Souza E.P., Luz K.G., Palatnik M., Palatnik de Sousa C.B. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine 2000, 19:1082-1092.
9. Dantas-Torres F. Leishmania infantum versus Leishmania chagasi: do not forget the law of priority. Mem. Inst. Oswaldo Cruz 2006, 101:117-118. discussion 118.
10. Davies H.T.O., Crombie I.K., Tavakoli M. When can odds ratios mislead?. Br. Med. J. 1998, 318:989.
11. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 2004, 27:305-318.
12. Dunan S., Frommel D., Monjour L., Ogunkolade B.W., Cruz A., Quilici M. Vaccination trial against canine visceral leishmaniasis. Parasite Immunol. 1989, 11:397-402. The Phocean Veterinary Study Group on Visceral, L.
13. Feliciangeli M.D., Delgado O., Suarez B., Chiurillo M.A. The burden of the Leishmania chagasi/infantum infection in a closed rural focus of visceral leishmaniasis in Lara state, west-central Venezuela. Trop. Med. Int. Health 2005, 10:444-449.
14. Gavgani A.S., Hodjati M.H., Mohite H., Davies C.R. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 2002, 360:374-379.
15. Genaro O., Pinto J.A., Da Costa C.A., Franca-Silva J.C., Costa R.T., Silva J.C., Sanguinetti L.S.R., Vieira E.P., Toledo V.P.C.P., Mayrink W. Phase III randomized double blind clinical trial on the efficacy of a vaccine against canine visceral leishmaniasis in urban area of Montes Claros, MG, Brazil. Mem. Inst. Osw. Cruz 1996, 91:116.
16. Giffoni J.H., de Almeida C.E., dos Santos S.O., Ortega V.S., de Barros A.T. Evaluation of 65% permethrin spot-on for prevention of canine visceral leishmaniasis: effect on disease prevalence and the vectors (Diptera: Psychodidae) in a hyperendemic area. Vet. Ther. 2002, 3:485-492.
17. Gradoni L., Foglia Manzillo V., Pagano A., Piantedosi D., De Luna R., Gramiccia M., Scalone A., Di Muccio T., Oliva G. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals. Vaccine 2005, 23:5245-5251. (Epub 2005 July, 5218).
18. Cochrane Handbook for Systematic Reviews of Interventions 2008, John Wiley & Sons Ltd., Chichester. J.P. Higgins, S. Green (Eds.).
19. Holzmuller P., Bras-Goncalves R., Lemesre J.L. Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania. Parasitology 2006, 132(Suppl.):S19-S32.
20. Lemesre J.L., Holzmuller P., Gonçalves R.B., Bourdoiseau G., Hugnet C., Cavaleyra M., Papierok G. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Vaccine 2007, 25:4223-4234.
21. Leontides L.S., Saridomichelakis M.N., Billinis C., Kontos V., Koutinas A.F., Galatos A.D., Mylonakis M.E. A cross-sectional study of Leishmania spp. infection in clinically healthy dogs with polymerase chain reaction and serology in Greece. Vet. Parasitol. 2002, 109:19-27.
22. Lima V.M.F., Ikeda F.A., Rossi C.N., Feitosa M.M., de Oliveira Vasconcelos R., Nunes C.M., Goto H. Diminished CD4+/CD25+ T cell and increased IFN-γ levels occur in dogs vaccinated with Leishmune® in an endemic area for visceral leishmaniasis. Vet. Immunol. Immunopathol. 2010, 135:296-302.
23. Maia C., Ramada J., Cristovao J.M., Goncalves L., Campino L. Diagnosis of canine leishmaniasis: conventional and molecular techniques using different tissues. Vet. J. 2009, 179:142-144. (Epub ahead of print).
24. Maroli M., Mizzoni V., Siragusa C., D'Orazi A., Gradoni L. Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin-impregnated dog collars in southern Italy. Med. Vet. Entomol. 2001, 15:358-363.
25. Mauricio I.L., Howard M.K., Stothard J.R., Miles M.A. Genomic diversity in the Leishmania donovani complex. Parasitology 1999, 119(Pt 3):237-246.
26. Mohebali M., Fallah E., Mobedi I., Hajjaran H. Field trial of autoclaved leishmania vaccines for control of canine visceral leishmaniasis in Meshkin-Shahr, Iran 1999, 87-92. Archives of Razi Institute.
27. Mohebali M., Khamesipour A., Mobedi I., Zarei Z., Hashemi-Fesharki R. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran. Vaccine 2004, 22:4097-4100.
28. Moher D., Liberati A., Tetzlaff J., Altman D.G., The P.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009, 6:e1000097.
29. Moreno J., Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol. 2002, 18:399-405.
30. ® vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine 2005, 23:4805-4810.
31. Noli C., Auxilia S.T. Treatment of canine Old World visceral leishmaniasis: a systematic review. Vet. Dermatol. 2005, 16:213-232.
32. ®) exposed to two consecutive Leishmania infantum transmission seasons. BSAVA Congress 2012, The ICC/NIA 2012, 529-530. Scientific Proceedings Veterinary Programme, Quedgeley.
33. Oliva G., Scalone A., Foglia Manzillo V., Gramiccia M., Pagano A., Di Muccio T., Gradoni L. Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons. J. Clin. Microbiol. 2006, 44:1318-1322.
34. Palatnik-de-Sousa C.B. Vaccines for canine leishmaniasis. Front. Immunol. 2012, 3:69.
35. Paradies P., Sasanelli M., de Caprariis D., Testini G., Traversa D., Lia R.P., Dantas-Torres F., Otranto D. Clinical and laboratory monitoring of dogs naturally infected by Leishmania infantum. Vet. J. 2010, 186:370-373.
36. Romero G.A., Boelaert M. Control of visceral leishmaniasis in latin america - a systematic review. PLOS Negl. Trop. Dis. 2010, 4:e584.
37. Roura X., Fondati A., Lubas G., Gradoni L., Maroli M., Oliva G., Paltrinieri S., Zatelli A., Zini E. Prognosis and monitoring of canine leishmaniasis. Veterinaria 2012, 26:9-16.
38. Solano-Gallego L., Koutinas A., Miro G., Cardoso L., Pennisi M.G., Ferrer L., Bourdeau P., Oliva G., Baneth G. Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. Vet. Parasitol. 2009, 165:1-18.
39. Solano-Gallego L., Llull J., Ramos G., Riera C., Arboix M., Alberola J., Ferrer L. The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection. Vet. Parasitol. 2000, 90:37-45.
40. Solano-Gallego L., Miro G., Koutinas A., Cardoso L., Pennisi M.G., Ferrer L., Bourdeau P., Oliva G., Baneth G., The LeishVet G. LeishVet guidelines for the practical management of canine leishmaniosis. Parasite. Vector. 2011, 4:86.
41. Solano-Gallego L., Morell P., Arboix M., Alberola J., Ferrer L. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J. Clin. Microbiol. 2001, 39:560-563.
42. Werneck G.L., Costa C.H., Walker A.M., David J.R., Wand M., Maguire J.H. Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil. Epidemiol. Infect. 2007, 135:195-201.
43. Wylie C.E., Carbonell-Antoñanzas M., Aiassa E., Dhollander S., Zagmutt F.J., Brodbelt D., Solano-Gallego L. A systematic review of the efficacy of prophylactic control measures for naturally-occurring canine leishmaniosis, part II. Prev. Vet. Med. 2014, 117:19-27.